These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31790)

  • 1. Cefoxitin sodium compatibility with intravenous infusions and additives.
    O'Brien MJ; Portnoff JB; Cohen EM
    Am J Hosp Pharm; 1979 Jan; 36(1):33-8. PubMed ID: 31790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
    Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1985 Oct; 42(10):2211-4. PubMed ID: 3864367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
    Bell RG; Lipford LC; Massanari MJ; Riley CM
    Am J Hosp Pharm; 1986 Jun; 43(6):1444-53. PubMed ID: 3728479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
    Rosenberg HA; Dougherty JT; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1980 Mar; 37(3):390-2. PubMed ID: 7369222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of parenteral solutions of tobramycin sulfate.
    Bergstrom RF; Fites AL; Lamb JW
    Am J Hosp Pharm; 1975 Sep; 32(9):887-8. PubMed ID: 242216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
    Gardella LA; Zaroslinski JF; Possley LH
    Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of common additives in protein hydrolysate/dextrose solutions.
    Kobayashi NH; King JC
    Am J Hosp Pharm; 1977 Jun; 34(6):589-94. PubMed ID: 406785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
    Galante LJ; Stewart JT; Warren FW; Johnson SM; Duncan R
    Am J Hosp Pharm; 1990 Jul; 47(7):1580-4. PubMed ID: 2368751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solution.
    Schuetz DH; King JC
    Am J Hosp Pharm; 1978 Jan; 35(1):33-44. PubMed ID: 623116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of netilmicin sulfate injection with commonly used intravenous injections and additives.
    Chaudry IA; Bruey KP; Hurlburt LE; Oden EM
    Am J Hosp Pharm; 1981 Nov; 38(11):1737-42. PubMed ID: 7304628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
    Floy BJ; Royko CG; Fleitman JS
    Am J Hosp Pharm; 1990 May; 47(5):1097-100. PubMed ID: 2337102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an ofloxacin injection in various infusion fluids.
    Bornstein M; Kao SH; Mercorelli M; Verma S
    Am J Hosp Pharm; 1992 Nov; 49(11):2756-60. PubMed ID: 1335206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.